The ACR is promoting federal legislation to eliminate high cost sharing for specialty tier medications in all states.
Magnify Rheumatology’s Legislative Impact this Month
Members of the ACR’s Executive, Government Affairs, and RheumPAC Committees, along with the Affiliate Society Council, attended 75 meetings with legislators and their staff. These meetings are critical to advancing awareness of rheumatology and the issues affecting your profession and patients.
ACR’s Advocacy Toolkit
Ways to contact your member of Congress; tips for communicating with your member of Congress; ways to get patients involved; and donloadable briefs, posters, and brochures.
ACR Partners with Patient Organizations
The ACR met with representatives from 14 patient advocacy organizations in Washington, D.C., to discuss mutual advocacy and legislative objectives.
ARHP Members Earn Leadership Position, Award
Kamala Nola, PharmD, MS, was inducted as the 2011-2012 president-elect of the Tennessee Pharmacists Association; Danuta Bujak, PhD, FNP, an ARHP member, was honored as the recipient of the 2011 Yale School of Nursing Distinguished Alumna Award.
Pointers for Rheumatologists Considering AMA Membership
Join the AMA. Don’t join because you agree with everything the AMA does. Join so we, as rheumatologists, will continue to have a voice and make a difference.
A Comparison of the Canadian and U.S. Healthcare Systems
The joys and the hazards of the Canadian single-payer universal healthcare program Canadian and the high-capacity and costly U.S. healthcare system.
ACR Leaders to Converge on Capitol Hill
In early March, leading members of Congress and other key policymakers will meet face to face with volunteer leaders of the ACR.
Data-Driven, Optimal Patient Care and Clinical Research
Expanded opportunities to advance rheumatology will be offered by ACR’s ongoing registry efforts
Health Policy Outlook for 2012
What’s in Store for Rheumatology in 2012?
- « Previous Page
- 1
- …
- 10
- 11
- 12
- 13
- 14
- …
- 20
- Next Page »